<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The aim of the study was to measure microcirculation parameters by dynamic contrast-enhanced MRI (d-MRI) and to evaluate the anti-angiogentic effects during treatment with thalidomide in different <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In 20 healthy <z:mpath ids='MPATH_458'>normal</z:mpath> persons, 20 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 10 patients with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) and 10 with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (MF) a fast gradient echo sequence (Turbo fast low angle shot 2D) with a pump controlled bolus infusion of <z:chebi fb="0" ids="33375">gadolinium</z:chebi>-<z:chebi fb="0" ids="35739">DTPA</z:chebi> was performed before and in 18 of these after beginning (average of 4.3 months) of a thalidomide therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Two pharmacokinetic parameters--the amplitude and exchange-rate-constant--were calculated and a statistical comparison of these values between healthy persons and patients as well as a correlation with the clinical course was executed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> controls the patients showed a higher amplitude (<z:mpath ids='MPATH_458'>normal</z:mpath> persons 14.4 +/- 5.2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> 24.8 +/- 8.1, MF 35.9 +/- 4.3, MM 23.4 +/- 3.6) and exchange-rate-constant (<z:mpath ids='MPATH_458'>normal</z:mpath> persons 0.124 +/- 0.042, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> 0.136 +/- 0.036, MF 0.144 +/- 0.068, MM 0.131 +/- 0.034) </plain></SENT>
<SENT sid="4" pm="."><plain>In the d-MRI-follow-up examinations a significant (p &lt; 0.005) reduction of the amplitude and exchange rate constant values was evident in 14 of 18 patients undergoing a thalidomide therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Clinically <z:hpo ids='HP_0000001'>all</z:hpo> of these patients showed a therapy responding with complete or partial diseases remission </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> significantly higher d-MRI-microcirculation parameters of the lumbar spine can be demonstrated than in <z:mpath ids='MPATH_458'>normal</z:mpath> persons </plain></SENT>
<SENT sid="7" pm="."><plain>During anti-angiogenetic treatment with thalidomide a decrease of these values was observed in case of a responding to therapy </plain></SENT>
</text></document>